No registrations found.
ID
Source
Brief title
Health condition
stroke, post-stroke shoulder pain
CVA, hemiplegische schouderpijn
Sponsors and support
Roessingh Rehabilitation Center
Intervention
Outcome measures
Primary outcome
Baseline assessment consists of a questionnaire that assesses pain complaints (current, past), clinical neurological tests (touch, temperature, sharpness) and tests for motor function. Moreover, general neurologic status and emotional status are assessed. Follow-up measurements consist of the assessment of pain complaints (quality, quantity) and the assessment of somatosensory and nociceptive changes using quantitative sensory testing and cold pressor testing.
Secondary outcome
1. Motor function;
2. Depression.
Background summary
Shoulder pain is a common complication after stroke and in some cases difficult to treat. Better prevention in the acute stroke phase and appropriate treatment in of shoulder pain may be accomplished when more is known about the neurophysiological mechanisms underlying the development and chronification of shoulder pain after stroke. The objective of the study is to identify somatosensory and nociceptive changes in the acute phase after stroke in relation to the development of shoulder pain.
Study objective
Shoulder pain is related to somatosensory and nociceptive changes in the acute phase after stroke. These changes may indicate the involvement of specific mechanisms (nociceptive, neuropathic) of post-stroke shoulder pain. Changes may either precede or follow the development of shoulder pain.
Study design
1. Baseline: 0-2 weeks post-stroke;
2. Follow up 1: 3 months post-stroke;
3. Follow up 2: 6 months post-stroke.
Intervention
N/A
M. Roosink
University of Twente, Biomedical Signals and Systems
Enschede 7500 AE
The Netherlands
+31 (0)53 4892740
m.roosink@utwente.nl
M. Roosink
University of Twente, Biomedical Signals and Systems
Enschede 7500 AE
The Netherlands
+31 (0)53 4892740
m.roosink@utwente.nl
Inclusion criteria
1. Older than 18 years;
2. Legally competent;
3. Able to communicate;
4. First-ever unilateral CVA (ischemic or hemorrhagic) of the middle cerebral artery (if possible confirmation by CT or MRI scan);
5. Somatosensory and motor loss during baseline measurement (0-2 weeks after stroke);
6. Sign informed consent.
Exclusion criteria
1. Pregnancy;
2. HIV/AIDS;
3. Any other brain disease (trauma, tumor, parkinson, multiple sclerosis);
4. Any peripheral neurological disease (amputation, neuropathy);
5. Pre-existent psychiatric disorders;
6. Pre-existent use of psychotropic substances or medication;
7. Chronic pain complaint (> 3 subsequent months) in the 6 months prior to stroke.
Design
Recruitment
Followed up by the following (possibly more current) registration
No registrations found.
Other (possibly less up-to-date) registrations in this register
No registrations found.
In other registers
| Register | ID |
|---|---|
| NTR-new | NL1648 |
| NTR-old | NTR1746 |
| Other | MEC Twente : P09-05 |
| ISRCTN | ISRCTN wordt niet meer aangevraagd |